Many employers are considering changes, including raising co-pays on prescription drugs to increase their employees' share of costs in a bid to curb growth in medical plan costs. Such cost-cutting actions should reduce employers' growth in costs next year to just below 6% instead of nearly 9% otherwise, suggest preliminary results of consultant Mercer's annual benefits survey.